PYGM Antibody (Center) Blocking Peptide
€363.00
In stock
SKU
AC-BP1450c
Background:
PYGM catalyzes and regulates the breakdown of glycogen to glucose-1-phosphate. Defects in PYGM are the cause of glycogen storage disease type 5 (GSD5), also known as McArdle disease. GSD5 is a metabolic disorder resulting in myopathy characterized by exercise intolerance, cramps, muscle weakness and recurrent myoglobinuria.
Other Names:
Glycogen phosphorylase, muscle form, Myophosphorylase, PYGM
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1450c was selected from the Center region of human PYGM. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PYGM (HGNC:9726)
Gene ID: 5837
Primary Accession: P11217
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
PYGM catalyzes and regulates the breakdown of glycogen to glucose-1-phosphate. Defects in PYGM are the cause of glycogen storage disease type 5 (GSD5), also known as McArdle disease. GSD5 is a metabolic disorder resulting in myopathy characterized by exercise intolerance, cramps, muscle weakness and recurrent myoglobinuria.
Other Names:
Glycogen phosphorylase, muscle form, Myophosphorylase, PYGM
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1450c was selected from the Center region of human PYGM. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: PYGM (HGNC:9726)
Gene ID: 5837
Primary Accession: P11217
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review